چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| Berberine (BBR) is an isoquinoline alkaloid belonging to the structural class of protoberberines. BBR has been used in traditional medicine to treat diseases, such as type 2 diabetes and hypercholesterolemia. BBR inhibits cancer cell growth and induces apoptosis. However, BBR has significant drawbacks as a chemotherapeutic agent, including poor solubility, and induction of drug resistance, limiting its application in chemotherapy. Hence, combination therapy could not only deal with the problems related to single-agent chemotherapy but could also improve the therapeutic index of anticancer drugs. Co-administration of drugs may show pharmaceutical incompatibility due to conflicting physicochemical features. BBR can be used in nanoparticle-based single drug delivery, and in co-delivery systems designed to accommodate drugs and deliver them simultaneously into cancer cells. In this review, we will summarize the use of BBR, including BBR as a single chemotherapeutic agent and the combination of BBR with traditional anti-cancer drugs or herbal medicines in nanoparticle-based delivery systems. |
| نویسنده | نفر چندم مقاله |
|---|---|
| حسین مجید زاده | اول |
| سید مصطفی اعرج خدایی | دوم |
| مریم غفاری | سوم |
| محمدعلی تربتی | چهارم |
| جعفر عزتی نژاد دولت آبادی | پنجم |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| Nano-based delivery systems for berberine.pdf | 1399/04/29 | 1860892 | دانلود |
